Target intelligence / Profile preview

Human selenoprotein family (SELENOs)

Target
SELENOs
Molecular classification
Enzyme, Transporter, Oxidoreductase, Calcium-binding protein
01

Overview

The human selenoprotein family consists of 25 proteins that incorporate the trace element selenium in the form of the amino acid selenocysteine (UniProt: P49908, Q9BQE3). These proteins are essential for various physiological processes, primarily acting as enzymes (oxidoreductases) that manage cellular redox balance and protect against oxidative damage (Labunskyy et al., 2014). Selenoprotein P (SELENOP) serves as the major selenium transport protein in the plasma and is a key biomarker for selenium status, with links to insulin resistance and metabolic syndrome (PubMed: 30107219). Selenoprotein N (SELENON) is localized in the endoplasmic reticulum and is critical for calcium regulation and muscle function; its deficiency leads to Selenoprotein N-related myopathy (NCBI: GeneID 57190). Selenoprotein K (SELENOK) plays a role in immune cell activation and the endoplasmic reticulum-associated degradation (ERAD) pathway (Reeves & Hoffmann, 2009). Therapeutically, these proteins are targeted through selenium supplementation to boost antioxidant defenses in cancer and cardiovascular disease, or through mimetics like ebselen (PubChem: CID 3194). However, the narrow therapeutic index of selenium requires careful monitoring to avoid toxicity or unintended metabolic consequences like selenosis.

Other names
SelenoproteinsSelenocysteine-containing proteinsSELENOPSELENONSELENOKGlutathione peroxidase (GPx)Thioredoxin reductase (TXNRD)Iodothyronine deiodinase (DIO)
02

Mechanism of action

Enhancement of selenoprotein biosynthesis through selenium supplementation or direct redox modulation by selenium mimetics (PubMed: 24510460).

03

Biological functions

Redox regulationSelenium transportCalcium homeostasisEndoplasmic reticulum-associated degradationThyroid hormone metabolismImmune response
04

Disease associations

CancerType 2 diabetesCongenital myopathyNeurodegenerative diseaseCardiovascular diseaseThyroid disorders
05

Safety considerations

Narrow therapeutic windowSelenosis (selenium toxicity)Potential risk of type 2 diabetes with chronic high intakePro-oxidant activity at supra-nutritional doses
06

Interacting drugs

Sodium selenite

3 more in the full profile.

07

Biomarkers

Plasma Selenoprotein P (SELENOP) levelsGlutathione peroxidase (GPx) activitySerum selenium concentration

Beyond the preview

Go deeper on Human selenoprotein family (SELENOs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human selenoprotein family (SELENOs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call